Fortrea Holdings, Inc. (FTRE)
18.31
-0.08
(-0.44%)
USD |
NASDAQ |
Aug 24, 16:00
18.55
+0.24
(+1.31%)
Pre-Market: 08:46
Fortrea Holdings Net Income (Quarterly) : -13.20M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.20M |
| March 31, 2026 | -23.60M |
| December 31, 2025 | -32.50M |
| September 30, 2025 | -15.90M |
| June 30, 2025 | -374.90M |
| March 31, 2025 | -562.90M |
| December 31, 2024 | -73.90M |
| September 30, 2024 | -18.50M |
| June 30, 2024 | -99.30M |
| Date | Value |
|---|---|
| March 31, 2024 | -79.80M |
| December 31, 2023 | -48.60M |
| September 30, 2023 | -16.10M |
| June 30, 2023 | 25.00M |
| March 31, 2023 | 8.00M |
| December 31, 2022 | 33.40M |
| September 30, 2022 | 60.60M |
| June 30, 2022 | 66.40M |
| March 31, 2022 | 32.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | -0.76M |
| IQVIA Holdings, Inc. | 258.00M |
| Medpace Holdings, Inc. | 121.36M |
| Personalis, Inc. | -31.68M |
| 10X Genomics, Inc. | -17.93M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 678.20M |
| Total Expenses (Quarterly) | 691.40M |
| EPS Diluted (Quarterly) | -0.1392 |
| Enterprise Value | 2.690B |
| Gross Profit Margin (Quarterly) | 17.63% |
| Profit Margin (Quarterly) | -1.95% |
| Earnings Yield | -5.00% |
| Operating Earnings Yield | 1.52% |
| Normalized Earnings Yield | -3.460 |